This NDC is on FDA's drug shortage list (posted Jul 26, 2023)

Reported reason: Demand increase for the drug

Product Information

METHYLPHENIDATE ER 63 MG TAB is a generic product labeled by Trigen Laboratories, LLC, priced at $18.8048 per EA under NDC 13811070030. Its NADAC has been published 123 times since Apr 17, 2024.

FDA first approved this application on Jun 23, 2022.

METHYLPHENIDATE ER 63 MG TAB

Methylphenidate hydrochloride
$18.8048per EA
DEA Schedule CII

Strength

63 mg/1

NDC

13811070030

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA216117

FDA Approved

6/23/2022

On Market Since

6/23/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER 63 MG TAB has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 6.4%. The table below summarizes its recorded NADAC range and movement.

Current price$18.8048 per EA
All-time high$19.1883 (Jan 14, 2026)
All-time low$15.5799 (Dec 18, 2024)
52-week high$19.1883
52-week low$18.1906
Median price$17.6659
Average price$17.5876
Largest weekly change-9.4% (Dec 18, 2024)
Weeks tracked123
Tracking sinceApr 17, 2024

Price History

1W

+1.3%

1M

+1.3%

3M

+2.7%

6M

-0.3%

1Y

-1.8%

3Y

N/A

5Y

N/A

All

+6.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylphenidate hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER 63 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 63 MG TAB, manufactured by Trigen Laboratories, LLC, is $18.8048 per EA (NDC 13811070030), effective Aug 19, 2026.

How has the price of METHYLPHENIDATE ER 63 MG TAB changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER 63 MG TAB has risen 6.4%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 63 MG TAB?

Since Apr 17, 2024, the NADAC for METHYLPHENIDATE ER 63 MG TAB has ranged from a low of $15.5799 (Dec 18, 2024) to a high of $19.1883 (Jan 14, 2026), with a median of $17.6659 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER 63 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE ER 63 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METHYLPHENIDATE ER 63 MG TAB?

METHYLPHENIDATE ER 63 MG TAB (NDC 13811070030) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.

Is METHYLPHENIDATE ER 63 MG TAB in shortage?

Yes — NDC 13811070030 is currently listed in FDA's drug shortage database (posted Jul 26, 2023). Reported reason: Demand increase for the drug.